Innate Pharma reports first half 2019 financial results and business update
Friday, September 13, 2019. Webcast and conference call will be held Friday, September 13 at 2:00pm (CEST)
Welcome to Innate Pharma
Scroll
About Innate Pharma
Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Headlines
ICML 2019: "TELLOMAK” clinical trial design and rationale and KOL webcast
A KOL webcast and conference call was held on Thursday, June 20, 2019
Innate Pharma announces publication of IPH4102 Phase I clinical trial results for CTCL in the Lancet Oncology
Publication in The Lancet Oncology of the results from the completed Phase I dose-escalation and expansion clinical trial of IPH4102 in advanced CTCL patients.